Table 1.
2018 | 2019 | 2020 | 2021 | 2022 | ||||
Total number of tests (n = 3759) | 1016 | 566 | 130 | 1171 | 876 | |||
Positive NS1 antigen/positive RT-PCR (n = 839) | 174 | 132 | 30 | 315 | 188 | |||
Positive serotyping (n = 495) | 127 | 86 | 1 | 178 | 103 | |||
Serotype | DENV1 | DENV2 | DENV3 | DENV1 | DENV3 | DENV3 | DENV3 | DENV3 |
Positive cases | 33 (26) | 52 (40.9) | 42 (33.1) | 7 (8.1) | 79 (91.9) | 1 (100) | 178 (100) | 103 (100) |
% male | 8 (6.3) | 12 (9.4) | 13 (10.2) | 2 (40) | 31 (55.36) | 19 (65.52) | 11 (55) | |
Mean age | 20 | 31 | 23 | 13 | 17 | 30 | 30 | |
Children and adolescent | 16 (12.6) | 19 (15) | 16 (12.6) | 4 (4.7) | 52 (60.5) | 0 | 53 (29.8) | 40 (38.8) |
Adult | 15 (11.8) | 32 (25.2) | 25 (19.7) | 3 (3.5) | 27 (31.4) | 1 (100) | 117 (65.7) | 59 (57.3) |
Elderly | 2 (1.6) | 1 (0.8) | 1 (0.8) | 0 | 0 | 0 | 8 (4.5) | 4 (3.9) |
Hospitalization | ||||||||
Inpatients n (%) | 13 (10.2) | 29 (22.8) | 22 (17.3) | 5 (5.8) | 64 (74.4) | 0 | 34 (19.1) | 21 (20.4) |
Admission day | 3 (1–5) | 4 (1–6) | 4 (1–7) | 3 (1–4) | 3 (1–9) | 3 (1–4) | 3 (1–4) | |
Days febrile | 4 (2–6) | 5 (2–8) | 5 (2–8) | 4 (2–6) | 5 (2–8) | 5 (2–8) | 5 (2–8) | |
Days in hospital | 5 (1–12) | 5 (1–8) | 5 (1–8) | 3 (1–5) | 5 (2–14) | 5 (1–11) | 5 (1–10) | |
Classical (%) | 12 (92.3) | 23 (79.3) | 16 (72.7) | 5 (100) | 29 (45.3) | 22 (64.7) | 14 (66.7) | |
Severe (%) | 1 (7.7) | 6 (20.7) | 6 (27.3) | 0 | 35 (54.7) | 12 (35.3) | 7 (33.3) | |
Sequence Analysis (n = 179) | 5 | 30 | 24 | 4 | 37 | 40 | 39 |